Ashis Mukhopadhya

Aberdeen, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus.

The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus.

Journal: The lancet. Gastroenterology & hepatology

Published: December 21, 2025

Leptospiral infection overlapping with autoimmune hepatitis: A diagnostic conundrum.

Leptospiral infection overlapping with autoimmune hepatitis: A diagnostic conundrum.

Journal: The journal of the Royal College of Physicians of Edinburgh

Published: November 13, 2025

Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial.

Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial.

Journal: Journal of hepatology

Published: March 21, 2025

Accuracy of Non-Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD: A Systematic Review.

Accuracy of Non-Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD: A Systematic Review.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: July 12, 2024

Volatile organic compounds for the detection of hepatocellular carcinoma-A scoping review.

Volatile organic compounds for the detection of hepatocellular carcinoma-A scoping review.

Journal: iLIVER

Published: July 21, 2023

European Association for Study of the Liver (EASL) clinical practice guidelines on haemochromatosis.

European Association for Study of the Liver (EASL) clinical practice guidelines on haemochromatosis.

Journal: Frontline gastroenterology

Published: August 15, 2022

Multidisciplinary pathway to support lifestyle change: tangible benefits in physical and mental health for patients with nonalcoholic fatty liver disease (NAFLD).

Multidisciplinary pathway to support lifestyle change: tangible benefits in physical and mental health for patients with nonalcoholic fatty liver disease (NAFLD).

Journal: Clinical liver disease

Published: July 25, 2022

Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group.

Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group.

Journal: The lancet. Gastroenterology & hepatology

Published: December 14, 2021

Widespread gaps in the quality of care for primary biliary cholangitis in UK.

Widespread gaps in the quality of care for primary biliary cholangitis in UK.

Journal: Frontline gastroenterology

Published: October 21, 2020

Fracture risk calculation tool enhances dual-energy X-ray absorptiometry scan referral pathway in cirrhosis patients.

Fracture risk calculation tool enhances dual-energy X-ray absorptiometry scan referral pathway in cirrhosis patients.

Journal: European journal of gastroenterology & hepatology

Published: June 03, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026